Temasek, Sequoia Capital back $90m round in China's JW Therapeutics

Temasek, Sequoia Capital back $90m round in China's JW Therapeutics

Photo: Bloomberg

A consortium of leading global investors including Temasek and Sequoia Capital China has joined the $90-million Series A financing round of Shanghai-based biotech startup JW Therapeutics, according to an official announcement.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter